Figure 3
From: Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
Regression analysis of MNC-NAIP levels and ALSFR-R. Eleven ALS patients at 4 months (case A1, A2, A6–A13, and A15) and 6 ALS patients at 12 months (Case A7–A12) were chosen for the evaluation of regression analysis. Correlations between the amount of MNC-NAIP and the rate of change in ALSFRS-R at 4 months (A) and 12 months (B) and between the rate of change in the amount of MNC-NAIP and the rate of change in ALSFRS-R at 4 months (C) and 12 months (D) are shown.
